作者:
Hideki,Makishima [1]
;
Ryunosuke,Saiki [1]
;
Yasuhito,Nannya [1]
;
Sophia,Korotev [2]
;
Carmelo,Gurnari [3]
;
June,Takeda [1]
;
Yukihide,Momozawa [4]
;
Steve,Best [5]
;
Pramila,Krishnamurthy [5]
;
Tetsuichi,Yoshizato [1]
;
Yoshiko,Atsuta [6]
;
Yusuke,Shiozawa [7]
;
Yuka,Iijima-Yamashita [8]
;
Kenichi,Yoshida [1]
;
Yuichi,Shiraishi [9]
;
Yasunobu,Nagata [1]
;
Nobuyuki,Kakiuchi [1]
;
Makoto,Onizuka [10]
;
Kenichi,Chiba [9]
;
Hiroko,Tanaka [11]
;
Ayana,Kon [1]
;
Yotaro,Ochi [1]
;
Masahiro M,Nakagawa [1]
;
Rurika,Okuda [1]
;
Takuto,Mori [1]
;
Akinori,Yoda [1]
;
Hidehiro,Itonaga [12]
;
Yasushi,Miyazaki [12]
;
Masashi,Sanada [8]
;
Takayuki,Ishikawa [13]
;
Shigeru,Chiba [14]
;
Hisashi,Tsurumi [15]
;
Senji,Kasahara [16]
;
Carsten,Müller-Tidow [17]
;
Akifumi,Takaori-Kondo [18]
;
Kazuma,Ohyashiki [19]
;
Toru,Kiguchi [20]
;
Fumihiko,Matsuda [21]
;
Joop H,Jansen [22]
;
Chantana,Polprasert [23]
;
Piers,Blombery [24]
;
Yoichiro,Kamatani [25]
;
Satoru,Miyano [26]
;
Luca,Malcovati [27]
;
Torsten,Haferlach [28]
;
Michiaki,Kubo [29]
;
Mario,Cazzola [27]
;
Austin G,Kulasekararaj [5]
;
Lucy A,Godley [2]
;
Jaroslaw P,Maciejewski [30]
;
Seishi,Ogawa [31]
作者单位:
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
[1]
Departments of Medicine and Human Genetics, Section of Hematology/Oncology, The University of Chicago, Chicago, IL.
[2]
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.;Department of Biomedicine and Prevention, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
[3]
Laboratory for Genotyping Development, Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama, Japan.
[4]
King's College Hospital NHS Foundation Trust, and King's College London, London, United Kingdom.
[5]
Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
[6]
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.;Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
[7]
Department of Advanced Diagnosis, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
[8]
National Cancer Center Research Institute, Division of Genome Analysis Platform Development, Tokyo, Japan.
[9]
Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
[10]
Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
[11]
Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
[12]
Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
[13]
Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
[14]
Department of Hematology, Gifu University, Gifu, Japan.
[15]
Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
[16]
Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
[17]
Department of Hematology, Kyoto University, Kyoto, Japan.
[18]
Department of Hematology, Tokyo Medical University, Tokyo, Japan.
[19]
Chugoku Central Hospital, Fukuyama, Japan.
[20]
Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
[21]
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
[22]
Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
[23]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[24]
Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
[25]
National Cancer Center Research Institute, Division of Genome Analysis Platform Development, Tokyo, Japan.;Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.;Medical and Dental, Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
[26]
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
[27]
MLL Munich Leukemia Laboratory, Munich, Germany.
[28]
Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
[29]
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
[30]
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.;Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.;Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
[31]
主题词
成年人(Adult);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);人类(Humans);男(雄)性(Male);DEAD-box RNA解旋酶类(DEAD-box RNA Helicases);生殖细胞(Germ Cells);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);突变(Mutation);骨髓增生异常综合征(Myelodysplastic Syndromes);骨髓增殖性疾病(Myeloproliferative Disorders)
DOI
10.1182/blood.2022018221
PMID
36322930
发布时间
2024-08-01
- 浏览2

Blood
Blood
534-549页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文